Cincinnati, OH, United States of America

Gary A Flynn


 

 

Average Co-Inventor Count = 2.7

ph-index = 14

Forward Citations = 789(Granted Patents)


Inventors with similar research interests:


Location History:

  • Madeira, OH (US) (1986 - 1988)
  • Cincinnati, OH (US) (1989 - 2000)
  • Broomall, PA (US) (2003)
  • Tucson, AZ (US) (1999 - 2018)
  • Oro Valley, AZ (US) (2013 - 2020)

Company Filing History:


Years Active: 1986-2020

Loading Chart...
Loading Chart...
Loading Chart...
81 patents (USPTO):

Title: The Innovative Contributions of Gary A. Flynn in Kinase Inhibition

Introduction: Gary A. Flynn, a prolific inventor based in Cincinnati, OH, has made significant strides in the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a remarkable portfolio of 81 patents, Flynn's contributions are influential in advancing medical research and therapeutic technology.

Latest Patents: Among his notable inventions are his latest patents related to JAK1 and ALK2 inhibitors. These patents detail compounds that possess inhibitory activity against ALK2 kinase and/or JAK2 kinase. The documents outline the structural characteristics of these compounds, which include stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs. Additionally, the patents describe methods for preparing and utilizing these compounds, as well as pharmaceutical compositions that incorporate them, indicating their potential for therapeutic applications.

Career Highlights: Flynn has had an impressive career, during which he has worked for renowned companies such as Merrell Dow Pharmaceuticals and Merrell Pharmaceuticals, Inc. His work in these organizations has been pivotal in the scientific exploration and commercialization of innovative pharmaceutical solutions.

Collaborations: Throughout his career, Flynn has collaborated with esteemed colleagues including Douglas Wade Beight and Alan M. Warshawsky. These collaborations highlight the importance of teamwork in the research and development sector, where sharing knowledge and expertise leads to groundbreaking advancements.

Conclusion: Gary A. Flynn’s extensive patent portfolio and his work on JAK1 and ALK2 inhibitors underscore his significant role in pharmaceutical innovations. His career trajectory reflects a blend of research excellence and collaboration, contributing to the evolving landscape of medical science and therapies aimed at combating various diseases. Flynn's work not only showcases individual creativity but also emphasizes the collaborative spirit that drives innovation in the pharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…